Stockscreener 앱 받기
15.54
4.37%
-0.71
시간 외 거래:
15.54
전일 마감가:
$16.25
열려 있는:
$15.93
하루 거래량:
1.33M
Relative Volume:
1.55
시가총액:
$1.21B
수익:
$1.64B
순이익/손실:
$-495.80M
주가수익비율:
-2.4266
EPS:
-6.404
순현금흐름:
$-45.25M
1주 성능:
-5.47%
1개월 성능:
-8.96%
6개월 성능:
+62.72%
1년 성능:
+0.97%
1일 변동 폭
$15.39
$16.04
1주일 범위
$15.39
$16.78
52주 변동 폭
$8.70
$20.49
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
명칭
Integra Lifesciences Holdings Corp
전화
(609) 275-0500
주소
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
15.54 | 1.26B | 1.64B | -495.80M | -45.25M | -6.404 |
ABT
Abbott Laboratories
|
103.36 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 다운그레이드 | Argus | Buy → Hold |
| 2025-03-31 | 업그레이드 | Argus | Hold → Buy |
| 2024-12-02 | 개시 | Morgan Stanley | Underweight |
| 2024-10-07 | 업그레이드 | BTIG Research | Sell → Neutral |
| 2024-07-30 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-07-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2024-05-07 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-12-05 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | 개시 | CL King | Buy |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-08 | 다운그레이드 | Argus | Buy → Hold |
| 2023-05-24 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-25 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2021-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-15 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-05-27 | 개시 | Citigroup | Neutral |
| 2020-04-03 | 개시 | SunTrust | Buy |
| 2020-01-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | 개시 | SunTrust | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-07 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-07-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Neutral |
| 2018-01-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-05-02 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | 개시 | UBS | Buy |
모두보기
Integra Lifesciences Holdings Corp 주식(IART)의 최신 뉴스
Integra LifeSciences on Track to Complete FDA Remediation in 2026 - Minichart
Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference - Yahoo Finance
Integra LifeSciences: Strong Q2 2026 Results Support Recovery Thesis (NASDAQ:IART) - Seeking Alpha
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Integra LifeSciences (IART) Investors of Pending Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm's Attorneys - TMX Newsfile
Is IART Still Attractive as Its Low Valuation Meets Execution Risks? - TradingView
Assenagon Asset Management S.A. Reduces Position in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Integra LifeSciences /US Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
Paradigm Capital discloses 4.42% Integra LifeSciences (IART) stake with sole voting control - Stock Titan
Integra LifeSciences (NASDAQ:IART) Stock Price Up 6.6%Time to Buy? - MarketBeat
Quantinno Capital Management LP Reduces Holdings in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Integra LifeSciences Holdings Corporation (IART) Interactive Stock Chart - Yahoo! Finance Canada
5 Must-Read Analyst Questions From Integra LifeSciences’s Q2 Earnings Call - Yahoo Finance
Integra LifeSciences Holdings Corporation $IART Stock Position Trimmed by Dimensional Fund Advisors LP - MarketBeat
IART 10-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Integra LifeSciences (IART) Investors with Substantial Losses to Contact the Firm Before Nov. 13th Deadline in Securities Fraud Class Action - TMX Newsfile
Glenmede Trust Co. NA Raises Stock Holdings in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Sells 96,400 Shares of Integra LifeSciences Holdings Corporation $IART - MarketBeat
List of 16 Acquisitions by Integra LifeSciences (Aug 2026) - Tracxn
integra lifesciences holdings corp Profit Warnings - RTTNews
Access Investment Management LLC Buys 268,085 Shares of Integra LifeSciences Holdings Corporation $IART - MarketBeat
Vanguard Portfolio Management (IART) discloses 3.9M-share position in Integra - Stock Titan
Integra LifeSciences Q2 2026 Earnings: Revenue, Financials, and SEC 10-Q Filing Highlights - Minichart
IART|Integra Lifesciences Holdings Corp|Price:18.245|Chg%:+0.005 - tradingkey.com
Integra Lifesciences Holdings Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Is Integra Lifesciences Holdings Corp (IART) Undervalued After Q - GuruFocus
Integra: Q2 Earnings Snapshot - kare11.com
Integra LifeSciences Reports Second Quarter 2026 Results, Updates Full-Year Revenue Guidance and Reaffirms EPS Outlook - Quiver Quantitative
Integra LifeSciences Reports Second Quarter 2026 Financial Results - Yahoo Finance Singapore
Integra LifeSciences (IART) Q2 Earnings Top Estimates - Yahoo Finance
Integra LifeSciences earnings up next: Can turnaround hold? - Investing.com
UBS initiates Integra LifeSciences stock with neutral rating - Investing.com
Ultrasonic Aspirator Market Size Projected to Reach USD 376.32 Million by 2035 | SNS Insider - GlobeNewswire Inc.
Integra LifeSciences (IART) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Institutional Confidence - TradingKey
Integra Lifesciences Holdings Corp (IART) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Integra Lifesciences Holdings Corp (IART) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Integra Lifesciences Holdings Corp - TradingKey
Integra LifeSciences (NASDAQ:IART) Reaches New 12-Month HighShould You Buy? - MarketBeat
IART|Integra Lifesciences Holdings Corp|Price:19.530|Chg%:-0.260 - TradingKey
Integra Lifesciences Holdings Corp (IART) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TradingKey - TradingKey
Integra Lifesciences Holdings Corp (IART) Cash Flow - TradingKey
Paradigm Capital Management Inc. NY Boosts Position in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Integra LifeSciences Holdings Corporation (IART) Stock Price, News, Quote & History - Yahoo! Finance Canada
Integra LifeSciences (NASDAQ:IART) Stock Price Up 6.4%Still a Buy? - MarketBeat
Kaskela Law Firm Announces Investigation of Integra LifeSciences - GuruFocus
Kaskela Law investigates Integra LifeSciences over alleged cGMP violations - scanx.trade
Integra LifeSciences (IART) to Announce Earnings on Wednesday - MarketBeat
Integra LifeSciences (NASDAQ:IART) Downgraded by Wall Street Zen to Buy - MarketBeat
How Integra LifeSciences’ Earnings Outperformance Track Record At Integra LifeSciences Holdings (IART) Has Changed Its Investment Story - Yahoo Finance
A Look at Integra Lifesciences Holdings Corp (IART) After 3.1% D - GuruFocus
Integra LifeSciences Holdings (IART) Stock Still Looks Below Fair Value Following A 70% Five Year Fall - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.29%
0.75%
자본화:
|
볼륨(24시간):